Controversies in the Treatment of Follicular Lymphoma
Abstract. The overall prognosis of patients with follicular lymphoma has substantially improved over the last decades with a 10-year overall survival of around 80% for the majority of patients. However, for most patients follicular lymphoma it is still a relapsing and remitting disease. Furthermore,...
| Published in: | HemaSphere |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-02-01
|
| Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000317 |